Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Bitran

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Chest|March 1, 1978
Clinicopathologic correlations demonstrating the failure of 67gallium scanning in determining response to radiotherapyJ D Bitran, T R DeMeester, K Rezai-Zadeh, et al.
Chest|July 1, 1989
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 studyE E Vokes, J D Bitran, P C Hoffman, et al.
Cancer Treatment Reports|September 1, 1981
Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot studyJ Ashenhurst, J D Bitran, E Robin, et al.
Cancer|February 1, 1983
Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapyJ D Bitran, R K Desser, C M Shapiro, et al.
American Journal of Clinical Oncology|October 1, 1992
The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancerW J Gradishar, R Mick, P C Hoffman, et al.
Cancer|May 1, 1982
Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastasesE Robin, J D Bitran, H M Golomb, et al.
Bone Marrow Transplantation|February 1, 1996
Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancerJ D Bitran, B Samuels, L Klein, et al.
Chest|December 1, 1979
Sequential staging in bronchogenic carcinomaU Mintz, T R DeMeester, H M Golomb, et al.
Seminars in Oncology|April 1, 1995
Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancerL C Drinkard, P C Hoffman, B L Samuels, et al.
Experimental Hematology|June 1, 1996
A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cellsS Roman-Unfer, J D Bitran, L Garrison, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Chest|March 1, 1978
Clinicopathologic correlations demonstrating the failure of 67gallium scanning in determining response to radiotherapyJ D Bitran, T R DeMeester, K Rezai-Zadeh, et al.
Chest|July 1, 1989
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 studyE E Vokes, J D Bitran, P C Hoffman, et al.
Cancer Treatment Reports|September 1, 1981
Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot studyJ Ashenhurst, J D Bitran, E Robin, et al.
Cancer|February 1, 1983
Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapyJ D Bitran, R K Desser, C M Shapiro, et al.
American Journal of Clinical Oncology|October 1, 1992
The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancerW J Gradishar, R Mick, P C Hoffman, et al.
Cancer|May 1, 1982
Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastasesE Robin, J D Bitran, H M Golomb, et al.
Bone Marrow Transplantation|February 1, 1996
Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancerJ D Bitran, B Samuels, L Klein, et al.
Chest|December 1, 1979
Sequential staging in bronchogenic carcinomaU Mintz, T R DeMeester, H M Golomb, et al.
Seminars in Oncology|April 1, 1995
Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancerL C Drinkard, P C Hoffman, B L Samuels, et al.
Experimental Hematology|June 1, 1996
A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cellsS Roman-Unfer, J D Bitran, L Garrison, et al.
Pageof 12